DK0921804T3 - Tofase oral præventionsmetode og kit som indeholder en kombination af progestin og østrogen - Google Patents

Tofase oral præventionsmetode og kit som indeholder en kombination af progestin og østrogen

Info

Publication number
DK0921804T3
DK0921804T3 DK97938011T DK97938011T DK0921804T3 DK 0921804 T3 DK0921804 T3 DK 0921804T3 DK 97938011 T DK97938011 T DK 97938011T DK 97938011 T DK97938011 T DK 97938011T DK 0921804 T3 DK0921804 T3 DK 0921804T3
Authority
DK
Denmark
Prior art keywords
progestin
estrogen
daily dosage
phase
combination
Prior art date
Application number
DK97938011T
Other languages
Danish (da)
English (en)
Inventor
Michael Jay Gast
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0921804T3 publication Critical patent/DK0921804T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Communication Control (AREA)
DK97938011T 1996-07-26 1997-07-23 Tofase oral præventionsmetode og kit som indeholder en kombination af progestin og østrogen DK0921804T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69042296A 1996-07-26 1996-07-26
PCT/US1997/012787 WO1998004265A1 (en) 1996-07-26 1997-07-23 Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen

Publications (1)

Publication Number Publication Date
DK0921804T3 true DK0921804T3 (da) 2003-11-24

Family

ID=24772384

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97938011T DK0921804T3 (da) 1996-07-26 1997-07-23 Tofase oral præventionsmetode og kit som indeholder en kombination af progestin og østrogen

Country Status (12)

Country Link
EP (1) EP0921804B1 (de)
JP (1) JP2000515889A (de)
KR (1) KR20000029536A (de)
CN (1) CN1186023C (de)
AT (1) ATE249222T1 (de)
AU (1) AU4043597A (de)
CA (1) CA2261748A1 (de)
DE (1) DE69724796T2 (de)
DK (1) DK0921804T3 (de)
ES (1) ES2205252T3 (de)
PT (1) PT921804E (de)
WO (1) WO1998004265A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
FR2801218B1 (fr) * 1999-11-23 2001-12-28 Hoechst Marion Roussel Inc Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant
EP1535618A1 (de) * 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmazeutische Zubereitung zur kontinuierlichen hormonellen Behandlung über einen Zeitraum von über 21-28 Tage beinhaltend zwei Estrogen und/oder Progestin Zusammensetzungen
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
DE102005034498A1 (de) * 2005-07-20 2007-01-25 Grünenthal GmbH Orale Kontrazeption mit Trimegeston
ATE424828T1 (de) * 2005-10-13 2009-03-15 Bayer Schering Pharma Ag Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
WO2008049172A1 (en) * 2006-10-27 2008-05-02 Vision Biosystems Limited A method and apparatus for dispensing substrates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4308406C1 (de) * 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung

Also Published As

Publication number Publication date
DE69724796D1 (de) 2003-10-16
ATE249222T1 (de) 2003-09-15
CN1186023C (zh) 2005-01-26
CN1226167A (zh) 1999-08-18
CA2261748A1 (en) 1998-02-05
EP0921804B1 (de) 2003-09-10
EP0921804A1 (de) 1999-06-16
JP2000515889A (ja) 2000-11-28
WO1998004265A1 (en) 1998-02-05
AU4043597A (en) 1998-02-20
DE69724796T2 (de) 2004-07-01
ES2205252T3 (es) 2004-05-01
PT921804E (pt) 2004-01-30
KR20000029536A (ko) 2000-05-25

Similar Documents

Publication Publication Date Title
BR9710566A (pt) M-todo anticoncepcional monof sico e um kit compreendendo uma combina-Æo de uma progestina e estrog-nio
CY1105276T1 (el) Τριφασικο στοματικο αντισυλληπτικο
AU645637B2 (en) Contraceptive regimen
DK0835114T3 (da) Farmaceutisk kombinationspræparat, kit og fremgangsmåde til den hormonale kontraception
DK0491415T3 (da) Orale svangerskabsforebyggende midler med lavt østrogen
WO1998004246A3 (en) Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
CA2542854A1 (en) Graduated estrogen contraceptive
DK0917466T3 (da) Oralt antikonceptionsmiddel
DK0921804T3 (da) Tofase oral præventionsmetode og kit som indeholder en kombination af progestin og østrogen
KR890009407A (ko) 폐경기증세 및 골다공증의 치료를 위한 약학적 투여단위